Tissue factor (coagulation factor III): a potential double-edge molecule to be targeted and re-targeted toward cancerSeyed Esmaeil Ahmadi(Iran University of Medical Sciences), Majid Safa(Iran University of Medical Sciences)Biomarker ResearchJune 6, 202310.1186/s40364-023-00504-6Cited by 48SaveCiteExport RISWatch citationsRelated PapersThe Prognostic Value of Thrombocytopenia in COVID-19 Patients; a Systematic Review and Meta-Analysis.|PubMed|2020|45Inhibition of DNA-PK enhances chemosensitivity of B-cell precursor acute lymphoblastic leukemia cells to doxorubicin|Biomedicine & Pharmacotherapy|2017|31Polymorphisms within methotrexate pathway genes: Relationship between plasma methotrexate levels, toxicity experienced and outcome in pediatric acute lymphoblastic leukemia.|PubMed|2020|28Pooled Prevalence Estimate of Ocular Manifestations in COVID-19 Patients: A Systematic Review and Meta-Analysis.|PubMed|2022|17